Building on previous research, Vivian Shi, M.D., discusses potential risks dermatologists will want to keep in mind when evaluating patients currently taking immunomodulator or immunosuppressant drugs. View the video interview here.
In case you missed it, Dermatology Times spoke with Mark Lebwohl, M.D., about biologic use in dermatology patients during the COVID-19 pandemic. View the video interview here.
